Press Releases


Published on Tuesday, June 8, 2021

APhA Commends Biden Administration’s Announcement of Actions to Address Pharmaceutical Supply Chain Vulnerabilities

WASHINGTON, D.C. – The American Pharmacists Association (APhA) commends the Biden administration’s announcement of new actions to address vulnerabilities in the pharmaceutical supply chain and strengthen our nation’s drug supply.

The administration’s announcement accompanied the release of the final report of the 100-day review called for in Executive Order (E.O.) 14017 “America’s Supply Chains.” APhA had welcomed E.O. 14017 and supports the administration’s efforts to protect our nation’s drug supply and mitigate shortages of both finished drug products and active pharmaceutical ingredients (APIs).

Highlights of the administration’s steps to protect and strengthen the pharmaceutical supply chain include the following:

  • Ensuring essential drugs are available: Establishing a public-private consortium for advanced manufacturing of medicines in the U.S. The initial focus will be on 50-100 drugs from the Food and Drug Administration's essential medicines list.
  • Onshore manufacturing of active pharmaceutical ingredients: Investing $60 million in the domestic production of APIs. 
  • Improving transparency: Greater insight throughout the pharmaceutical supply chain. 
  • Strengthen global supply chain: Working with allies and partners to decrease vulnerabilities in global supply chains.

“Our nation’s drug supply is a strategic asset and tightening the predictability, accountability, and accessibility of essential medicines and their ingredients is essential for pharmacists to provide patient care,” said Ilisa Bernstein, APhA Senior Vice President of Pharmacy Practice and Government Affairs.  “COVID has shown us the fragility of the drug supply and the Administration’s new steps will strengthen the integrity and robustness of drug availability in the U.S.”

APhA stands ready to assist the administration in this important initiative. Ensuring an adequate drug supply during the COVID-19 public health emergency and beyond will enable pharmacists to continue caring for their patients without disruption.     

About the American Pharmacists Association

The American Pharmacists Association is only organization advancing the entire pharmacy profession. Our expert staff, and strong volunteer leadership, including many experienced pharmacists, allow us to deliver vital leadership to help pharmacists, pharmaceutical scientists, student pharmacists and pharmacy technicians find success and satisfaction in their work, while advocating for changes that benefit them, their patients and their communities. For more information, please visit


CONTACT: Frank Fortin


Rate this article:
No rating
Comments (0)Number of views (2584)
Please login or register to post comments.